| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 150.229 | 192.414 | 341.636 | 342.384 | 340.367 | 193.638 | 455.550 | 461.737 | 486.392 |
| Total Income - EUR | 0 | 150.358 | 192.926 | 342.156 | 342.704 | 341.125 | 194.378 | 455.550 | 478.535 | 490.057 |
| Total Expenses - EUR | 6 | 120.256 | 167.851 | 279.947 | 265.673 | 244.539 | 89.977 | 287.665 | 353.152 | 343.415 |
| Gross Profit/Loss - EUR | -6 | 30.102 | 25.075 | 62.209 | 77.031 | 96.586 | 104.401 | 167.885 | 125.383 | 146.642 |
| Net Profit/Loss - EUR | -6 | 24.525 | 22.614 | 58.791 | 74.206 | 93.819 | 102.503 | 163.761 | 120.509 | 133.839 |
| Employees | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Endotechnology Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 130 | 0 | 21.168 | 11.529 | 258 | -29 | 730 | 2.730 | 32.421 | 23.877 |
| Current Assets | 2 | 40.284 | 146.746 | 347.723 | 242.919 | 285.792 | 326.370 | 422.588 | 345.953 | 479.535 |
| Inventories | 0 | 16.779 | 63.333 | 44.329 | 104.128 | 55.936 | 120.739 | 54.753 | 82.156 | 52.974 |
| Receivables | 0 | 4.555 | 74.569 | 277.424 | 79.621 | 134.308 | 108.723 | 295.330 | 256.051 | 424.485 |
| Cash | 2 | 18.950 | 8.844 | 25.970 | 59.170 | 95.549 | 96.908 | 72.505 | 7.746 | 2.075 |
| Shareholders Funds | -30 | 24.540 | 27.659 | 85.942 | 74.329 | 93.939 | 194.358 | 163.879 | 120.626 | 146.018 |
| Social Capital | 45 | 89 | 88 | 86 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 162 | 15.744 | 140.255 | 273.311 | 168.937 | 191.870 | 132.783 | 261.467 | 257.747 | 358.500 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Endotechnology Srl